Literature DB >> 7754837

Expression of PDGF, PDGF-receptor, EGF-receptor and sex hormone receptors on meningioma.

J I Kuratsu1, H Seto, M Kochi, Y Ushio.   

Abstract

The expression of platelet derived growth factors (PDGF), the PDGF-Receptor (R) (alpha and beta types), epidermal growth factor (EGF)-Receptor (R) and sex hormone (oestrogen and progesterone) receptors was studied in 22 meningiomas. All tumours were PDGF-R beta type positive and 21 (95%) were PDGF positive. Only 2 (9%) were PDGF-R alpha type positive, 13 (59%) were EGF-R positive. The expression of these proteins was not related to the histological type or the malignancy of the meningiomas although the expression of PDGF and PDGF-R beta tended to be stronger in malignant meningiomas. Oestrogen and progesterone receptor protein were examined in 19 patients (10 females and 9 males). None of the meningioma cells revealed oestrogen receptor protein while 17 (89%) of the 19 meningiomas were positive for progesterone receptor protein. The expression of progesterone receptor was not related to histological type or malignancy. Our studies suggest that the autocrine system, through PDGF and PDGF-R type beta, may play an important role in the tumourigenicity of meningiomas. EGF-R was present in almost half and progesterone receptor in most of the meningiomas. There was no correlation between the expression of either PDGF, PDGF-R or EGF-R and the expression of progesterone receptor protein.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7754837     DOI: 10.1007/BF01808629

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  29 in total

1.  Coincidence of EGF receptors and somatostatin receptors in meningiomas but inverse, differentiation-dependent relationship in glial tumors.

Authors:  J C Reubi; U Horisberger; W Lang; J W Koper; R Braakman; S W Lamberts
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

2.  Human meningiomas co-express platelet-derived growth factor (PDGF) and PDGF-receptor genes and their protein products.

Authors:  M Maxwell; T Galanopoulos; E T Hedley-Whyte; P M Black; H N Antoniades
Journal:  Int J Cancer       Date:  1990-07-15       Impact factor: 7.396

3.  Enhanced expression of the sis and c-myc oncogenes in human meningiomas.

Authors:  K Kazumoto; M Tamura; H Hoshino; Y Yuasa
Journal:  J Neurosurg       Date:  1990-05       Impact factor: 5.115

4.  Effects of progesterone on the response to epidermal growth factor and other growth factors in cultured human meningioma cells.

Authors:  J W Koper; J A Foekens; R Braakman; S W Lamberts
Journal:  Cancer Res       Date:  1990-05-01       Impact factor: 12.701

5.  Radioimmunoassay of human platelet-derived growth factor using monoclonal antibody toward a synthetic 73-97 fragment of its B-chain.

Authors:  T Shiraishi; S Morimoto; K Itoh; H Sato; K Sugihara; T Onishi; T Ogihara
Journal:  Clin Chim Acta       Date:  1989-09-15       Impact factor: 3.786

6.  Epidermal growth factor receptor expression in 72 meningiomas.

Authors:  N R Jones; M L Rossi; M Gregoriou; J T Hughes
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

7.  Oncogene amplification in pediatric brain tumors.

Authors:  J C Wasson; R L Saylors; P Zeltzer; H S Friedman; S H Bigner; P C Burger; D D Bigner; A T Look; E C Douglass; G M Brodeur
Journal:  Cancer Res       Date:  1990-05-15       Impact factor: 12.701

8.  Estrogen-receptor protein in intracranial meningiomas.

Authors:  M S Donnell; G A Meyer; W L Donegan
Journal:  J Neurosurg       Date:  1979-04       Impact factor: 5.115

9.  Estrogen and progesterone receptors in meningiomas in relation to clinical and pathologic features.

Authors:  T M Markwalder; D T Zava; A Goldhirsch; R V Markwalder
Journal:  Surg Neurol       Date:  1983-07

10.  Expression of platelet-derived growth factors, transforming growth factors, and the ros gene in a variety of primary human brain tumors.

Authors:  T Mapstone; M McMichael; D Goldthwait
Journal:  Neurosurgery       Date:  1991-02       Impact factor: 4.654

View more
  5 in total

1.  Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma.

Authors:  David A Reardon; Andrew D Norden; Annick Desjardins; James J Vredenburgh; James E Herndon; April Coan; John H Sampson; Sridharan Gururangan; Katherine B Peters; Roger E McLendon; Julie A Norfleet; Eric S Lipp; Jan Drappatz; Patrick Y Wen; Henry S Friedman
Journal:  J Neurooncol       Date:  2011-09-22       Impact factor: 4.130

Review 2.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

3.  Progesterone-receptor index in meningiomas: correlation with clinico-pathological parameters and review of the literature.

Authors:  Stefan Wolfsberger; Soroush Doostkam; Hans-Gerd Boecher-Schwarz; Karl Roessler; Michael van Trotsenburg; Johannes A Hainfellner; Engelbert Knosp
Journal:  Neurosurg Rev       Date:  2004-05-27       Impact factor: 3.042

4.  Expression and clinical value of EGFR in human meningiomas.

Authors:  Magnus B Arnli; Thomas Backer-Grøndahl; Borgny Ytterhus; Unn S Granli; Stian Lydersen; Sasha Gulati; Sverre H Torp
Journal:  PeerJ       Date:  2017-03-29       Impact factor: 2.984

5.  Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.

Authors:  C Pfister; H Pfrommer; M S Tatagiba; F Roser
Journal:  Br J Cancer       Date:  2012-10-09       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.